In December 2020, Servier Pharmaceuticals LLC bought Agios Pharmaceuticals Inc.’s approved acute myeloid leukemia drug, Tibsovo (ivosidenib), and the rest of its oncology business in a deal valued at up to $2 billion. Now, the U.S. FDA has approved one of those assets, with the brand name Voranigo (vorasidenib), for treating gliomas. Read More

Sangamo Therapeutics Inc. put pen to paper on a would-be $1.9 billion-plus deal with Genentech, a unit of Roche AG, to develop intravenously administered genomic drugs for neurodegenerative conditions. Read More

China’s Genor Biopharma Co. Ltd. agreed to out-license GB-261, its bispecific antibody candidate primarily targeting B-cell lymphomas, to TRC 2004 Inc., a U.S.-based newco co-founded by Third Rock Ventures LLC and Two River Group Holdings LLC. Read More

With time running out on the 118th U.S. Congress, a group of lawmakers is urging the leadership of the House Energy and Commerce Committee to consider a bipartisan path forward on strengthening the 340B drug discount program. Read More

Researchers in Japan were able to transfer genes from jellyfish into common fruit flies and discovered that the transferred gene suppressed an age-related intestinal issue in the flies. The findings suggest that studying genes specific to animals with high regenerative capability like jellyfish may uncover new mechanisms for rejuvenating stem cell function and extending the healthy lifespan of unrelated organisms. Read More

From no hope to viable treatments, BioWorld  is there to cover the breakthroughs in medicine. Listen to Randy Osborne explain why the BioWorld  team is ‘always on the lookout for what's next.’ Read More

New hires and promotions in the biopharma industry, including: 89bio, ALX Oncology, Cellectis, Cyclerion, Melinta, Quotient. Read More

Biopharmas raising money in public or private financings, including: Artax, Neurotherapia, Quantro, Release, Shinobi, Symbiotic, Tenax. Read More

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Concentric, Elevation, Equillium, Levicept, TFF, Tris. Read More

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aytu, Biomarin, Daiichi, Dong-A, Immunoforge, Merck & Co., Neurobo. Read More

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Exelixis, George Medicines, Indapta, Sellas. Read More